A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization

被引:14
|
作者
Lopez-Guillermo, Armando
Canales, Miguel A.
Dlouhy, Ivan
Briones, Javier
Caballero, Dolores
Sancho, Juan Manuel, Sr.
Vilchez, Santiago Mercadal
Moraleda, Jose Maria
Terol, Maria Jose
Salar, Antonio
Palomera, Luis
Gardella, Santiago
Jarque, Isidro
Ferrer, Secundino
Bargay, Joan
Lopez, Andres
Panizo, Carlos
Muntanola, Anna
Montalban, Carlos
Conde, Eulogio
Hernandez, Miguel
Soler, Alfons
Marin, Julian
Marco, Jose Garcia
Deben, Guillermo
Tomas, Jose Francisco
机构
关键词
D O I
10.1182/blood.V122.21.369.369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 2 条
  • [1] A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
    Lopez-Guillermo, Armando
    Canales, Miguel Angel
    Dlouhy, Ivan
    Mercadal, Santiago
    Briones, Javier
    Martin Garcia-Sancho, Alejandro
    Sancho, Juan Manuel
    Maria Moraleda, Jose
    Terol, Maria Jose
    Salar, Antonio
    Palomera, Luis
    Gardella, Santiago
    Jarque, Isidro
    Ferrer, Secundino
    Bargay, Joan
    Lopez, Andres
    Panizo, Carlos
    Muntanola, Anna
    Montalban, Carlos
    Conde, Eulogio
    Hernandez, Miguel T.
    Soler, Alfons
    Garcia Marco, Jose A.
    Deben, Guillermo
    Marin, Julian
    Tomas, Jose Francisco
    LEUKEMIA & LYMPHOMA, 2022, 63 (01) : 93 - 100
  • [2] Two years rituximab maintenance vs. observation after first-line treatment with bendamustine plus rituximab (B-R) in patients with mantle cell lymphoma: First results of a prospective, randomized, multicenter phase II study (a subgroup study of the StiL NHL7-2008 MAINTAIN trial).
    Rummel, Mathias J.
    Knauf, Wolfgang
    Goerner, Martin
    Soeling, Ulrike
    Lange, Elisabeth
    Hertenstein, Bernd
    Eggert, Jochen
    Schliesser, Georg C.
    Weide, Rudolf
    Blumenstengel, Klaus
    Detlefsen, Ninia
    Hinke, Axel
    Kauff, Frank
    Barth, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)